Pancreatic Cancer Action Network Launches Precision Promise
Vitalograph Launches New In2itive e-Diary
Medidata Launches myMedidata LIVE
PPD to Open Multipurpose Research Laboratory in China
Strategikon Launches Two New Business Operation Services
WCG Announces the Formation of WCG IRB and Launch of WCG IRB Connexus
BARDA Selects Pharm-Olam to Support Trial Planning & Execution
SubjectWell and Reify Health Examine Patient Concerns and Safety Protocols
COVID-19 Clinical Trial Resumptions Slow as Cases Rise Again
New Centre for Medicines Research Report from Clarivate Indicates Drug Development Timelines are Shortest Since 2013
Pharmaceutical R&D industry report provides insights into what’s behind decline in global NME outputs and reveals implications of decreased projected expenditures.
Care Access Research Partners on Mobile Trial for COVID-19 Treatment
Elevation Oncology and US Oncology Research Collaborate to Expand Genomic Testing in Phase II Study
Life Sciences Professionals Believe COVID-19 Must Change Trial Management
Phlexglobal Partners with PRA Health Sciences to Create the Global TMF Center of Excellence
Veeva and Bioforum Partner with RedHill Biopharma on Phase II/III COVID-19 Data
Medable Launches TeleConsent
Parexel Completes Purchase of Roam Analytics’ NLP Capability
PRA Health Sciences and Deep Lens Announce Partnership for Precision Cancer Trials
Regulatory and Quality Solutions LLC Acquires Maetrics
FHI Clinical Inc. Expands Support in PREVAIL Research Network
Business and People News
The latest industry happenings from the past month, all in one place.
CATO SMS Acquires Array Biostatistics
Sharp Launches Clinventory IMS
Phesi Data Shows COVID-19 Impact on Trial Suspensions Continue
Cytel Acquires Laiya Consulting
Clinerion Announces New Partnership with Maxer Consulting
Florence Healthcare Supports Pfizer’s COVID-19 Vaccine Trials
A New Interest in Autism Genomic Therapy Development
Sangamo executives, Melita Sun Jung and Amy Pooler, discuss the future of genomic medicines for autism spectrum disorder.
COVID-19 Causes 67% of Experts to use Decentralized Trials in Future, says GlobalData
Parexel and Pfizer Enter Next Phase of Partnership
